Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anton Jm Loonen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacogenomics and Personalized Medicine|August 31, 2016
Comments on Lucire and Crotty, 2011Anton Jm Loonen, Robbert-Jan Verkes
Journal of Psychopharmacology (Oxford, England)|September 27, 2018
The evolutionary old forebrain as site of action to develop new psychotropic drugsAnton Jm Loonen, Svetlana A Ivanova
Journal of Psychopharmacology (Oxford, England)|September 9, 2020
Neurobiological mechanisms associated with antipsychotic drug-induced dystoniaAnton Jm Loonen, Svetlana A Ivanova
Pharmacogenomics|November 6, 2019
Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophreniaAnton Jm Loonen, Bob Wilffert, Svetlana A Ivanova
Pharmacogenomics and Personalized Medicine|July 28, 2018
The functional variant rs334558 of <i>GSK3B</i> is associated with remission in patients with depressive disordersAnastasia Levchenko, Innokentiy S Losenkov, Natalia M Vyalova, et al.
SAGE Open Medicine|April 30, 2016
Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populationsSvetlana A Ivanova, Anton Jm Loonen, P Roberto Bakker, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacogenomics and Personalized Medicine|August 31, 2016
Comments on Lucire and Crotty, 2011Anton Jm Loonen, Robbert-Jan Verkes
Journal of Psychopharmacology (Oxford, England)|September 27, 2018
The evolutionary old forebrain as site of action to develop new psychotropic drugsAnton Jm Loonen, Svetlana A Ivanova
Journal of Psychopharmacology (Oxford, England)|September 9, 2020
Neurobiological mechanisms associated with antipsychotic drug-induced dystoniaAnton Jm Loonen, Svetlana A Ivanova
Pharmacogenomics|November 6, 2019
Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophreniaAnton Jm Loonen, Bob Wilffert, Svetlana A Ivanova
Pharmacogenomics and Personalized Medicine|July 28, 2018
The functional variant rs334558 of <i>GSK3B</i> is associated with remission in patients with depressive disordersAnastasia Levchenko, Innokentiy S Losenkov, Natalia M Vyalova, et al.
SAGE Open Medicine|April 30, 2016
Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populationsSvetlana A Ivanova, Anton Jm Loonen, P Roberto Bakker, et al.
Pageof 1